LPA, lipoprotein(a), 4018

N. diseases: 340; N. variants: 49
Disease: Chronic kidney disease stage 5 ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5 		0.070 GeneticVariation disease BEFREE Nontraditional cardiovascular risk factors such as lipoprotein(a) (Lp(a)), the genetic polymorphisms of apolipoprotein(a), apolipoprotein E (ApoE), and apolipoprotein B (ApoB) increase the prevalence of atherosclerosis in end-stage renal disease (ESRD) through quantitative and qualitative alterations. 31119518 2019
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5 		0.070 AlteredExpression disease BEFREE We sought to examine PON activity and Apo A-I levels in patients with ESRD vs healthy controls. 30920627 2019
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5 		0.070 Biomarker disease BEFREE Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease. 30071823 2018
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5 		0.070 Biomarker disease BEFREE Plasma lipoprotein (a) (LP(a)) concentrations are increased in patients with end-stage renal disease. 9736817 1998
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5 		0.070 Biomarker disease BEFREE Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease. 9237283 1997
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5 		0.070 Biomarker disease BEFREE Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism. 8272223 1993
CUI: C2316810
Disease: Chronic kidney disease stage 5
Chronic kidney disease stage 5 		0.070 Biomarker disease BEFREE Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). 8432847 1993